Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-18

Clinical Trial Update: Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial evaluating the efficacy, safety, and pharmacokinetics of human anti-D (rh) immunoglobulin (Rhesoglobin) in pregnant women, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rhesoglobin (human anti-D immunoglobulin) (anti-D immunoglobulin)

Snippet

Sponsor: Biopharma Plasma LLC | Conditions: Pregnancy Related | Phase 4 | Status: RECRUITING